CHEMM ChemoMetec

Major shareholder announcement – Swedbank Robur Fonder AB

Major shareholder announcement – Swedbank Robur Fonder AB

ANNOUNCEMENT NO. 259



Major shareholder announcement



Major shareholder announcement – Swedbank Robur Fonder AB         

Pursuant to Section 38 of the Danish Capital Markets Act, it is hereby announced that Swedbank Robur Fonder AB has informed ChemoMetec A/S that Swedbank Robur Fonder AB on 2 April 2024, decreased its holding of shares and voting rights to below 5% of the total share capital and voting rights in ChemoMetec A/S.



Additional information

Niels Høy Nielsen, CFO

Telephone (+45) 2551 8724



About ChemoMetec A/S

ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec’s instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec’s customers include some of the world’s leading pharmaceutical companies, such as Novartis, Novo Nordisk, H. Lundbeck, Merck, AstraZeneca and Johnson & Johnson.

ChemoMetec was founded in 1997 and is listed on Nasdaq OMX Copenhagen. For more information, go to



EN
03/04/2024

Underlying

CHEMMChemoMetec

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ChemoMetec

 PRESS RELEASE
Free
CHEMM CHEMOMETEC

Major shareholder announcement – BlackRock, Inc.

Major shareholder announcement – BlackRock, Inc. ANNOUNCEMENT NO. 266 Major shareholder announcement Major shareholder announcement – BlackRock, Inc.          Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed ChemoMetec A/S that BlackRock Investment Management (UK) Limited on 13 May 2024, decreased its holding of voting rights attached to shares and voting rights in ChemoMetec A/S to below 10%, and that the holding thus is below the 10 per cent limit in section 38 of the Capital Markets Act. The aggregate holding of shares a...

22h / 37m 1 EN
 PRESS RELEASE
Free
CHEMM CHEMOMETEC

Storaktionærmeddelelse – BlackRock, Inc.    

Storaktionærmeddelelse – BlackRock, Inc.     MEDDELELSE NR. 266 Storaktionærmeddelelse Storaktionærmeddelelse – BlackRock, Inc.          I henhold til kapitalmarkedslovens § 30 skal det hermed oplyses, at BlackRock, Inc. har meddelt ChemoMetec A/S, at BlackRock Investment Management (UK) Limited d. 13. maj 2024 har nedbragt sin beholdning af stemmerettigheder tilknyttet aktier og stemmerettigheder i ChemoMetec A/S til under 10%, og besiddelsen dermed er under 10% procentgrænsen i kapitalmarkedslovens § 38. BlackRock, Inc.’s samlede beholdning af aktier og stemmerettigheder i ChemoMe...

22h / 37m 1 EN
Free Trial
CHEMM CHEMOMETEC

ChemoMetec A S: 2 directors

Two Directors at ChemoMetec A S bought 2,437 shares at between 305.000DKK and 310.000DKK. The significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over th...

05/15/24 May 15, 2024 1 EN
 PRESS RELEASE
Free
CHEMM CHEMOMETEC

Indberetning af ledende medarbejderes transaktioner

Indberetning af ledende medarbejderes transaktioner MEDDELELSE NR. 265 Indberetning af ledende medarbejderes transaktioner ChemoMetec A/S har i henhold til artikel 19 i forordning (EU) nr. 596/2014 modtaget nedenstående indberetning om transaktioner i ChemoMetec A/S aktier udført af personer med ledelsesansvar og/eller personer, der er nært knyttet til dem. Se indberetning af bestyrelsesmedlem Peter Reichs transaktioner i vedhæftede pdf-dokument. Yderligere oplysninger kan fås ved henvendelse til: Niels Høy Nielsen, CFO Telefon: (+45) 25 51 87 24         Om ChemoMetec A/S C...

May 14, 2024 1 EN
 PRESS RELEASE
Free
CHEMM CHEMOMETEC

Notification of managers’ transactions

Notification of managers’ transactions ANNOUNCEMENT NO. 265 Notification of managers’ transactions ChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation no. 596/2014 of transactions related to shares in ChemoMetec A/S made by persons discharging managerial responsibilities in ChemoMetec A/S and/or persons closely associated with them. See the transactions of member of the Board of Directors Peter Reich in the attached PDF document. For further information, please contact: Niels Høy Nielsen, CFOTelephone (+45) 2551 8724 About ChemoMetec...

May 14, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch